RNA, U7 small nuclear 65 pseudogene (RNU7-65P)

**RNA, U7 small nuclear 65 pseudogene (RNU7-65P)** is a pseudogene related to the U7 small nuclear RNA (snRNA) gene family. Like other processed pseudogenes, it is a non-functional genomic DNA sequence that resembles the functional U7 snRNA gene, but it does not encode a functional RNA product[2][4][5][6]. Functional U7 snRNA is normally an essential component of the U7 small nuclear ribonucleoprotein (snRNP) complex critical for 3′ end processing of replication-dependent histone pre-mRNA, but RNU7-65P itself is a "pseudogene," meaning it does not contribute to biological activity or known disease processes[1][2]. There are no known drugs targeting this pseudogene, no biomarker utilities, and it is not considered a therapeutic target. **Key Context and Essential Details:** - **Pseudogenes** like RNU7-65P are recognized by their sequence homology to functional genes but are classified as "non-functional" due to mutations, truncations, or regulatory sequence loss that prevent proper transcription or function[2][6]. - Only the functional **U7 snRNA** is implicated in biomedically relevant processes, primarily *histone pre-mRNA processing*[1][3]. RNU7-65P, as a pseudogene, is not known to have any biological function or disease role. **Summary Assessment:** - RNU7-65P is a **pseudogene** and **not a therapeutic target**. - There is nothing to suggest it is misspelled, but it is *not a functional biological target*; thus **is_incorrect** should be marked true for most therapeutic, biomarker, or drug discovery contexts.

Other names

U7.65RNU7-65P